Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer

Published:2021-01 Issue: Volume:26 Page:15-23
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Wilson George D.,Wilson Thomas G.,Hanna Alaa,Dabjan Mohamad,Buelow Katie,Torma John,Marples Brian,Galoforo Sandra

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference67 articles.

1. Common and distinct elements in cellular signaling via EGF and FGF receptors;Schlessinger;Science,2004

2. Hayes DN, Grandis J, El-Naggar AK. Comprehensive genomic characterization of squamous cell carcinoma of the head and neck in the Cancer Genome Atlas. In Proceedings of the 104th Annual Meeting of the American Association for Cancer Research. Washington, DC. Philadelphia (PA): AACR; Cancer Res; 2013.

3. The mutational landscape of head and neck squamous cell carcinoma;Stransky;Science,2011

4. The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies;Martin;Oncotarget,2014

5. Exploiting the head and neck cancer oncogenome: widespread PI3K-mTOR pathway alterations and novel molecular targets;Iglesias-Bartolome;Cancer Discovery,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Profile of Canine Hemangiosarcoma and Potential Novel Therapeutic Targets;Veterinary Sciences;2023-06-05

2. Pharmacological PI3K inhibition in head and neck squamous cell carcinoma: A systematic review;Toxicology in Vitro;2023-04

3. DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival;International Journal of Molecular Sciences;2023-02-01

4. Targeted therapy for head and neck cancer: signaling pathways and clinical studies;Signal Transduction and Targeted Therapy;2023-01-16

5. Emerging tyrosine kinase inhibitors for head and neck cancer;Expert Opinion on Emerging Drugs;2022-07-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3